Association between Icotinib Efficacy and Circulating Tumor Cell Levels in Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Huang, Y. [1 ]
Wang, W. [2 ]
Xu, C. [3 ]
Zhuang, W. [1 ]
Song, Z. [2 ]
Huang, Z. [1 ]
Lin, G. [1 ]
Chen, X. [4 ]
Wu, B. [1 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
机构：
[1] Fujian Prov Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Prov Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Prov Canc Hosp, Thorac Surg, Fuzhou, Fujian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
icotinib; non-small cell lung cancer; Circulating tumor cells;
D O I：
10.1016/j.jtho.2017.09.1450
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-008
引用
收藏
页码：S2203 / S2203
页数：1
相关论文
共 50 条
  • [1] Efficacy of Icotinib Hydrochloride in the Treatment of Advanced Non-small Cell Lung Cancer
    Ma Xianglei
    Tang Yiqun
    Kou Yingying
    Shi Meiqi
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (03): : 85 - 89
  • [2] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Aiqin Gu
    Chunlei Shi
    Liwen Xiong
    Tianqing Chu
    Jun Pei
    Baohui Han
    ChineseJournalofCancerResearch, 2013, 25 (01) : 90 - 94
  • [3] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Gu, Aiqin
    Shi, Chunlei
    Xiong, Liwen
    Chu, Tianqing
    Pei, Jun
    Han, Baohui
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 90 - 94
  • [4] Circulating Ghrelin levels in advanced Non-Small Cell Lung Cancer
    Karapanagiotou, Eleni M.
    Polyzos, Aris
    Dilana, Kalliopi D.
    Boura, Paraskevi G.
    Gratsias, Ioannis
    Ioannis, Gkiozos
    Syrigos, Kostas N.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S716 - S717
  • [5] CIRCULATING GHRELIN LEVELS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Karapanagiotou, E. M.
    Boura, P.
    Dilana, K.
    Xyla, V.
    Liappa, C.
    Gratsias, I.
    Polyzos, A.
    Syrigos, K. N.
    ANNALS OF ONCOLOGY, 2008, 19 : 115 - 115
  • [6] Efficacy and influence factors of icotinib hydrochloride in treating advanced non-small cell lung cancer
    Ma, X. -H.
    Tian, T. -D.
    Liu, H. -M.
    Li, Q. -J.
    Gao, Q. -L.
    Li, L.
    Shi, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (02) : 266 - 274
  • [7] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2018, 119 : 42 - 47
  • [8] Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Park, C.
    Oh, H.
    Kim, M.
    Kim, B.
    Cho, H.
    Oh, I.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S418 - S418
  • [9] Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer
    He, Wenjie
    Li, Wenhui
    Jiang, Bo
    Chang, Li
    Jin, Congguo
    Tu, Changlin
    Li, Yunfen
    ONCOTARGETS AND THERAPY, 2016, 9 : 7515 - 7520
  • [10] Detecting circulating tumor cells in patients with advanced non-small cell lung cancer
    Xu, Y. H.
    Zhou, J.
    Pan, X. F.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10352 - 10358
12345